| # | % | |||||
|---|---|---|---|---|---|---|
| 101 | FIDELITY NATIONAL FINANCIAL | 30,000 | 832,000 | 0.00% | ||
| 102 | UNITED TECHNOLOGIES CORP | 8,000 | 845,000 | 0.00% | ||
| 103 | APTARGROUP INC | 14,129 | 858,000 | 0.00% | ||
| 104 | METLIFE INC | 16,800 | 902,000 | 0.00% | ||
| 105 | DONEGAL GROUP INC | 59,500 | 914,000 | 0.00% | ||
| 106 | SIGMA ALDRICH | 7,500 | 1,020,000 | 0.00% | ||
| 107 | EQUITY COMWLTH COM SH BEN INT | 40,000 | 1,028,000 | 0.00% | ||
| 108 | LIPOSCIENCE INC | 200,000 | 1,036,000 | 0.00% | ||
| 109 | ELECTRO RENT CORP | 82,000 | 1,129,000 | 0.00% | ||
| 110 | PHILIP MORRIS INTL INC | 13,800 | 1,151,000 | 0.00% | ||
| 111 | NOVARTIS A G | 12,848 | 1,209,000 | 0.00% | ||
| 112 | SIRIUS XM HOLDINGS INC | 350,000 | 1,222,000 | 0.00% | ||
| 113 | AMERICAN INDEPENDENCE CORP | 125,611 | 1,321,000 | 0.00% | ||
| 114 | BROOKFIELD PPTY PARTNERS L P | 65,000 | 1,370,000 | 0.00% | ||
| 115 | Monster Beverage Corpo | 15,000 | 1,375,000 | 0.00% | ||
| 116 | OncoGenex Pharmaceuticals Inc | 515,512 | 1,376,000 | 0.00% | ||
| 117 | XYLEM INC | 39,100 | 1,388,000 | 0.00% | ||
| 118 | KULICKE & SOFFA INDS INC | 100,000 | 1,423,000 | 0.00% | ||
| 119 | LORAL SPACE & COMMUNICATIONS | 20,000 | 1,436,000 | 0.00% | ||
| 120 | Park City Group Inc | 150,000 | 1,479,000 | 0.00% | ||
| 121 | ATHERSYS INC NEW | 1,197,796 | 1,665,000 | 0.00% | ||
| 122 | MIRATI THERAPEUTICS INC COM | 99,912 | 1,749,000 | 0.00% | ||
| 123 | Allergan plc | 10,000 | 1,782,000 | 0.00% | ||
| 124 | LIMONEIRA CO | 78,197 | 1,852,000 | 0.00% | ||
| 125 | ISHARES TR | 30,000 | 1,924,000 | 0.00% | ||
| 126 | SANOFI | 34,157 | 1,927,000 | 0.00% | ||
| 127 | INTERNATIONAL BUSINESS MACHS | 10,252 | 1,946,000 | 0.00% | ||
| 128 | UNUM GROUP | 60,000 | 2,063,000 | 0.01% | ||
| 129 | Medical Action Industries Inc OLD | 150,000 | 2,067,000 | 0.01% | ||
| 130 | NOVAVAX INC COM | 500,000 | 2,085,000 | 0.01% | ||
| 131 | LEUCADIA NATL CORP | 88,000 | 2,098,000 | 0.01% | ||
| 132 | HEADWATERS INC | 2,000,000 | 2,170,000 | 0.01% | ||
| 133 | STARZ SERIES A | 73,355 | 2,427,000 | 0.01% | ||
| 134 | KALOBIOS PHARMACEUTICALS INC | 1,746,591 | 2,707,000 | 0.01% | ||
| 135 | JPMORGAN CHASE & CO | 45,943 | 2,768,000 | 0.01% | ||
| 136 | LORILLARD | 50,000 | 2,996,000 | 0.01% | ||
| 137 | AMERIPRISE FINL INC | 25,260 | 3,117,000 | 0.01% | ||
| 138 | ArQule Inc | 2,843,599 | 3,185,000 | 0.01% | ||
| 139 | CELLDEX THERAPEUTICS INC NEW | 250,000 | 3,240,000 | 0.01% | ||
| 140 | UNIQURE NV | 352,000 | 3,242,000 | 0.01% | ||
| 141 | S&P GLOBAL INC | 40,000 | 3,378,000 | 0.01% | ||
| 142 | MORGANS HOTEL GROUP CO | 430,000 | 3,470,000 | 0.01% | ||
| 143 | CHINA YUCHAI INTL LTD | 200,000 | 3,708,000 | 0.01% | ||
| 144 | CONCUR TECHNOLOGIE | 30,000 | 3,805,000 | 0.01% | ||
| 145 | SWS GROUP INC | 553,108 | 3,811,000 | 0.01% | ||
| 146 | SHIRE PLC | 15,000 | 3,886,000 | 0.01% | ||
| 147 | THRESHOLD PHARMACEUTICAL INC | 1,091,700 | 3,941,000 | 0.01% | ||
| 148 | PFIZER INC | 135,661 | 4,011,000 | 0.01% | ||
| 149 | VERASTEM INC | 512,254 | 4,364,000 | 0.01% | ||
| 150 | GERON CORP | 2,198,124 | 4,396,000 | 0.01% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001325447-14-000056, filed 2014.11.13).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
